Generally, incretin hormones such as GLP-1 and GIP are released from intestinal L-cells and play an essential role in physiologically mediating insulin secretion after a meal [14]
Some caution about breakouts and recommend pairing with vitamin C or antioxidants for best results
Almost every woman has it, but nobody wants to show it: cellulite, also known as orange peel syndrome
Insurance Coverage Predictions CagriSema (Advantage: Semaglutide Component): Leverages Wegovy's established coverage "Combination of proven medication + new molecule" easier sell to insurers Predicted coverage: 50-60% of commercial plans initially Retatrutide (Challenge: Novel Molecule): Entirely new drug class, no established coverage Higher efficacy but also higher side effects Will likely require trial-and-failure of cheaper options Predicted coverage: 40-50% of commercial plans initially Clinical Trial Populations and Indications CagriSema: Diabetes Focus REDEFINE-1: Obesity without diabetes (3,417 participants) REDEFINE-2: Obesity WITH type 2 diabetes (1,206 participants) REIMAGINE Program: Additional diabetes-focused trials Advantage: Strong diabetes data positions CagriSema for dual obesity + diabetes indications, like tirzepatide (Mounjaro/Zepbound)
doi: 10.1038/s41568-019-0149-1 67 ShimadaKSkoutaRKaplanAYangWSHayanoMDixonSJet al
Fucking, their crocodiles are angry
